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Abstract: The direct and stereocontrolled addition of (S)-4-isopropyl-
N-(2-pivaloyloxyacetyl)-1,3-thiazolidine-2-thione to dialkyl acetals of 
aromatic and a,b-unsaturated aldehydes catalyzed by 2.5–5 mol% of 
a nickel(II) complex permits the synthesis of diastereomerically pure 
and fully protected anti aldol adducts in good to high yields. The 
catalytic species is formed in situ from commercially available and 
easy to handle (Me3P)2NiCl2, which makes this reaction a direct, 
catalytic, and experimentally simple approach to the asymmetric anti 
glycolate aldol reaction. 
Introduction 
The widespread presence of 1,2,3-trioxygenated arrays in natural 
products and the synthetic interest for such structural motifs have 
stimulated the development of a variety of stereoselective and 
catalytic transformations.[1] Thereby, the enantioselective 
epoxidation of allylic alcohols and the dihydroxylation of olefins 
both disclosed by Sharpless are foremost landmarks in 
asymmetric catalysis and hold a prominent position among all 
asymmetric procedures.[2] Besides them, Mukaiyama aldol 
reactions from protected a-hydroxy enol silyl ethers are often 
used to get stereocontrolled access to the abovementioned 
trioxygenated structural motifs.[3] Despite the undeniable synthetic 
potential of these methods, there is a lasting quest for direct, 
catalytic, and more efficient constructive methods.[4] In this 
context, organocatalysis leads the way and mono- and 
dihydroxyacetone have become excellent platforms from which to 
carry out enantioselective aldol reactions under mild conditions.[5] 
Surprisingly, there is a lack of parallel reactions proceeding 
through metal enolates that, in principle, might give access to a 
broader range of trioxygenated motifs.[6] Pioneering studies by 
Shibasaki established that the direct aldol reaction of 
hydroxyacetophenone, catalyzed by heterobimetallic and zinc 
BINOL-derived complexes, afforded anti or syn glycolate aldol 
derivatives respectively in high yields with a remarkable 
stereocontrol.[7] At the same time, Trost reported similar results 
with zinc ProPhenol catalysts, which produce syn glycolate aldol 
adducts with high yields and enantioselectivities and good 
diastereomeric ratios.[8,9] Further improvements utilized other aryl 
a-hydroxymethyl ketones or amides[10] and were applied to the 
synthesis of natural products,[11] but few significant advances 
have been reported since then. Interestingly, Shibasaki described 
a related enantioselective aldol addition of a-sulfanyl 7-
azaindolinylamide catalyzed by a copper(I) complex,[12,13] 
whereas Aoki has recently reported that direct aldol reactions of 
a protected dihydroxyacetone with aromatic aldehydes catalyzed 
by zinc complexes containing histidine produce syn aldol adducts 
with good yields and enantioselectivities.[14] In view of the lack of 
methods to prepare anti glycolate adducts and taking advantage 
of our experience with stoichiometric reactions of titanium(IV) 
enolates with acetals[15,16] and direct and highly stereoselective 
carbon-carbon bond forming reactions from chiral N-acyl-1,3-
thiazolidene-2-thiones catalyzed by nickel(II) complexes,[17,18] we 
envisaged that Lewis acid-mediated glycolate aldol-like additions 
to dialkyl acetals might proceed in a highly efficient manner. 
Importantly, such an approach was supported by the high yields 
and diastereomeric ratios achieved in the direct addition of N-
azidoacetyl-4-isopropyl-1,3-thiazolidine-2-thione to dialkyl acetals 
promoted by 2–5 mol% of (Me3P)2NiCl2, a commercially available 
and easy to handle complex (Scheme 1).[19] Herein, we disclose 
our results on the direct reaction of protected N-hydroxyacetyl-4-
isopropyl-1,3-thiazolidine-2-thiones with dialkyl acetals triggered 
by (Me3P)2NiCl2, which produces the corresponding anti adducts 
with good to high yields in a stereocontrolled manner. 
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Results and Discussion 
Using previously optimized conditions from a related 
reaction,[19,20] we initially explored the feasibility of the process 
and the influence of the hydroxyl protecting group on the direct 
addition of N-hydroxyacetyl thiazolidinethiones 1–7 to the 
dimethyl acetal of 4-methoxybenzaldehyde (a). As shown in Table 
1, most of the evaluated substrates give good diastereomeric 
ratios but with variable yields. Concretely, ethers and silyl ether 
protected hydroxyacetyl thiazolidinethiones 1–5 gave good 
diastereoselectivities but in moderate or low yields (entries 1–5 in 
Table 1), whereas those containing ester protecting groups 
resulted much more favorable (entry 6 and 7 in Table 1). 
Particularly, the pivaloyl group was chosen as the most suitable 
protecting group because of the high diastereoselectivity (dr 
87:13) and the simplicity of the chromatographic purification, 
which permitted us to isolate pure anti adduct 14a with a 77% 
yield by using a tiny 2.5 mol% of (Me3P)2NiCl2. Further analyses 
indicated that reaction times greater than five hours were required 
(entries 7–9 in Table 1), so the standard time was fixed for 15 h 
to ensure the completion of any reaction. 
The scope of the reaction was first examined with a variety of 
aromatic dimethyl acetals.[21] The aldol addition proceeded 
smoothly for activated acetals (a and b in Table 2) using the 
abovementioned experimental conditions (2.5 mol% of 
(Me3P)2NiCl2 and 1.15 equivalents of TESOTf). However, it was 
necessary to increase the (Me3P)2NiCl2 loading and the amount 
of TESOTf to 5 mol% and 2.2 equivalents respectively when less 
activated acetals (c–g in Table 2) were used to achieve adequate 
yields.[22] 
The method was next applied to dialkyl acetals from a,b-
unsaturated aldehydes. Addition to 1.1 equivalents of dimethyl 
acetals from cinnamic aldehydes h and i afforded the expected 
anti adducts 14h and 14i with diastereomeric ratios of 78:22 and 
93:7 with yields up to 89% (Table 3). In turn, parallel reactions 
with less reactive cobalt-substituted propargylic diethyl 
acetals[23,24] j and k needed 1.5 equivalents of the electrophile, 5 
mol% of (Me3P)2NiCl2, and 2.2 equivalents of TESOTf to give the 
desired adducts 14j and 14k with high yields and 




Table 1. Influence of the hydroxyl protecting group on the addition to the dimethyl acetal of 4-methoxybenzaldehyde (a) 
 
 
Entry Substrate PG Reaction time (h) Adduct Dr[a] Yield (%)[b] 
1 1 TES 15 8a 90:10 26 
2[c] 2 TBS 15 9a 86:14 49 
3 3 TBDPS 15 10a 75:25 19 
4 4 Bn 15 11a 88:12 61 
5 5 Me 15 12a 89:11 36 
6 6 Bz 15 13a 83:17 73 
7 7 Piv 15 14a 87:13 77 
8 7 Piv 5 14a 87:13 71 
9 7 Piv 1.5 14a 87:13 57 
[a] Established by 1H NMR analysis of the reaction mixtures. [b] Isolated yield of the anti adduct after chromatographic purification. [c] TBSOTf was used instead of 





1.1 equiv 4-MeOC6H4CH(OMe)2 (a), 2.5 mol% (Me3P)2NiCl2













Table 2. Direct addition of 7 to dimethyl acetals of aromatic aldehydes a 
 
[a] The diastereomeric ratios were established by 1H NMR analysis of the reaction mixtures. The yields indicate the anti adduct 14a–g isolated after chromatographic 
purification. 
Table 3. Direct addition of 7 to dialkyl acetals of a,b-unsaturated aldehydes a 
 
[a] The diastereomeric ratios were established by 1H NMR analysis of the reaction mixtures. The yields indicate the anti adduct 14h–k isolated after chromatographic 
purification. 
 
Finally, the search for aldol adducts possessing easily removable 
protecting groups led us to assess the addition to diallyl and 
dibenzyl acetals from 4-methoxybenzaldehyde (m and n 
respectively). Both acetals performed well and furnished both 
adducts 14m and 14n with high diastereoselectivities and yields, 
only slightly lower than those obtained with the dimethyl 
counterpart a (Table 4). All together, these examples show that 
the direct glycolate aldol reaction from chiral thiazolidinethione 7 
catalyzed by a nickel(II) complex gives access to anti adducts 14 
in high yields. These adducts may be considered as protected 
a,b-dihydroxy carboxylic compounds, which can be easily 




CH2Cl2, –20 °C, 15 h
1.1 equiv ArCH(OMe)2, (Me3P)2NiCl2


































































dr 80:20     anti 60%
NS OPiv
S O
CH2Cl2, –20 °C, 15 h
1.5 equiv RCH(OR1)2, cat (Me3P)2NiCl2









































dr 94:6     anti 74%






Table 4. Direct addition of 7 to diallyl and dibenzyl acetals of 4-
methoxybenzaldehyde a 
 
[a] The diastereomeric ratios were established by 1H NMR analysis of the 
reaction mixtures. The yields indicate the anti adduct 14 after chromatographic 
purification 
A mechanistic proposal to account for the stereoselective addition 
of 7 to acetals is represented in Scheme 2. Taking advantage of 
Sodeoka’s proposal for the conversion of nickel(II) chlorides into 
the more active triflates by treatment of the former species with 
R3SiOTf,[25] we hypothesize that (Me3P)2Ni(OTf)2 is the real 
catalyst of the process. Then, coordination of (Me3P)2Ni(OTf)2 to 
7 activates the Ca, which can be deprotonated by the base to 
produce a nickel(II) enolate. At the same time, TESOTf interacts 
with the acetal and triggers the formation of an oxocarbenium 
intermediate that finally approaches the less hindered p-face of 













Scheme 2. Plausible mechanism for the adiition of 7 to dialkyl acetals. 
Conclusions 
In summary, the direct Lewis acid-mediated reactions of (S) 4-
isopropyl-N-(2-pivaloyloxyacetyl)-1,3-thiazolidine-2-thione with 
aromatic and a,b-unsaturated dialkyl acetals catalyzed by 2.5–5 
mol% of (Me3P)2Ni(OTf)2, prepared in situ from commercially 
available and easy to handle (Me3P)2NiCl2, give the 
corresponding anti glycolate diastereomers with a high 
stereocontrol and yields under mild conditions. 
Experimental Section 
General Information. Unless otherwise stated, reactions were conducted 
in oven-dried glassware under an inert atmosphere of nitrogen with 
anhydrous solvents. The solvents and reagents were dried and purified 
when necessary according to standard procedures. All commercial 
reagents were used as received. Column chromatography was carried out 
under low-pressure (flash) conditions and performed on SDS silica gel 60 
(35−70 μm). Eluents are indicated in brackets in each case. Analytical thin-
layer chromatographies (TLC) were carried out on Merck silica gel 60 F254 
plates and analyzed by UV (254 nm) and stained with phosphomolybdic 
acid or 4-methoxybenzaldehyde. Rf values are approximate. Melting points 
(Mp) were determined with a Stuart Scientific SMP10 or a Gallenkamp 
apparatus and are uncorrected. Specific rotations ([α]) were determined at 
589 nm (D-line) and at 20 °C on a PerkinElmer 241 MC polarimeter. IR 
spectra were recorded on a Nicolet 6700 FT-IR Thermo Scientific 
spectrometer. The samples were analyzed as a compacted powder mixed 
with KBr (solids), over a NaCl tablet (liquid or oil) or using ATR technique 
(Attenuated Total Reflectance). Only the more representative frequencies 
(ν) are reported. 1H NMR (400 MHz) and 13C NMR (100.6 MHz) spectra 
were recorded on a Varian Mercury 400 spectrometer or on a Bruker 400. 















dr 84:16   anti 73%
14n































































0.00 for 1H NMR) or CDCl3 (δ 77.0 for 13C NMR). Data are reported as 
follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br, broad 
(and their corresponding combinations). When necessary, 2D techniques 
(COSY and HSQC) were also used to assist with structure elucidation. 
High-resolution mass spectra (HRMS) were obtained with an Agilent 1100 
spectrometer with a TOF analyzer by the Unitat d’Espectrometria de 
Masses, Universitat de Barcelona. 
Acylation of (S)-4-isopropyl-1,3-thiazolidine-2-thione: Synthesis of 
(S)-N-acyl-4-isopropyl-1,3-thiazolidine-2-thiones 3–5 and 7 
The starting material, (S)-4-isopropyl-1,3-thiazolidine-2-thione, was 
prepared from (S)-2-amino-3-methyl-1-butanol according to a procedure 
reported in the literature.[27] 
(S)-N-(2-tert-Butyldiphenylsilyloxyacetyl)-4-isopropyl-1,3-
thiazolidine-2-thione (3):[16] Neat TBDPSCl (5.2 mL, 20 mmol) was added 
to a suspension of methyl glycolate (1.56 mL, 16.8 mmol) and imidazole 
(2.72 g, 40 mmol) in CH2Cl2 (20 mL) at 0 °C under N2 and the reaction 
mixture was stirred for 36 h at room temperature. It was diluted with Et2O 
(100 mL) and washed with H2O (2 ´ 30 mL), 2 M HCl (2 ´ 30 mL), and 
brine (30 mL). The organic layer was dried over MgSO4, filtered, and 
concentrated. 
A solution of the protected ester in THF (15 mL) was treated with 1 M KOH 
in 2:1 v/v H2O/MeOH (8.5 mL) and the reaction mixture was stirred for 3 h 
at 0 °C. It was diluted with Et2O (70 mL) and washed with H2O (2 ́  50 mL). 
The aqueous layer was acidified with 2 M HCl until pH 1. Then, it was 
extracted with Et2O (2 ´ 75 mL), the combined organic extracts were 
washed with brine (50 mL), dried over MgSO4, filtered, and concentrated 
to give 1.725 g (5.48 mmol, 33% overall yield) of 2-tert-
butyldiphenylsilyloxyacetic acid, which was used in the next step without 
further purification. 
Oxalyl chloride (0.56 mL, 6.6 mmol) was carefully added to a dry solution 
of 2-tert-butyldiphenylsilyloxyacetic acid (1.23 g, 3.9 mmol) in benzene 
(6.6 mL) at room temperature under N2. The resulting solution was stirred 
for 30 min at room temperature and 30 min at reflux. The organic layer was 
dried over MgSO4, filtered and concentrated. The volatiles were removed 
in vacuo and the resulting acid chloride was used in the next step without 
further purification.  
A 1.55 M solution of n-BuLi in hexanes (2.4 mL, 3.3 mmol) was added 
dropwise to a solution of (S)-4-isopropyl-1,3-thiazolidine-2-thione (484 mg, 
3.0 mmol) in THF (1.5 mL) at –78 °C under N2 and the reaction mixture 
was stirred for 15 min. Then, a solution of 2-tert-butyldiphenylsilyloxyacetyl 
chloride (1.085 g, 3.26 mmol) in THF (1.5 mL) was carefully added and the 
resulting clear solution was stirred for 5 min at –78 °C and 1.5 h at room 
temperature. The reaction mixture was cooled with an ice bath and 
quenched with sat NH4Cl (1.5 mL). This mixture was extracted with CH2Cl2 
(3 ´ 20 mL) and the combined organic extracts were dried over MgSO4 
and filtered. The solvent was removed in vacuo and the crude was purified 
by flash column chromatography (hexanes/EtOAc 95:5) to give 783 mg 
(1.71 mmol, 57% yield) of 3 as a yellow oil. Rf (hexanes/EtOAc 95:5) = 
0.20. [α]D20 = +140 (c = 0.95, CHCl3). IR (ATR) n = 2961, 2872, 1716, 1364, 
1313, 1114 cm–1. 1H NMR (CDCl3, 400 MHz) d = 7.73–7.66 (5H, m), 7.43–
7.34 (5H, m), 5.20 (1H, ddd, J = 8.1, 6.2, 1.2 Hz), 3.46 (1H, dd, J = 11.6, 
8.1 Hz), 2.99 (1H, dd, J = 11.6, 1.2 Hz), 2.44–2.33 (1H, m), 1.11 (9H, s), 
0.98 (3H, d, J = 6.9 Hz), 0.90 (3H, d, J = 6.9 Hz). 13C NMR (CDCl3, 100.6 
MHz) d = 202.0 (C), 172.1 (C), 135.9 (CH), 135.6 (CH), 133.1 (C), 133.0 
(C), 129.8 (CH), 129.7 (CH), 127.7 (CH), 127.6 (CH), 71.4 (CH), 66.8 (CH2), 
31.3 (CH2), 30.6 (CH), 26.8 (C), 19.3 (CH3), 19.0 (CH3), 17.5 (CH3). 
(S)-N-(2-Benzyloxyacetyl)-4-isopropyl-1,3-thiazolidine-2-thione (4):[16] 
A 1.6 M solution of n-BuLi in hexanes (2.4 mL, 3.3 mmol) was added 
dropwise to a solution of (S) 4-isopropyl-1,3-thiazolidine-2-thione (484 mg, 
3.0 mmol) in THF (2 mL) at –78 °C under N2 and the reaction mixture was 
stirred for 15 min. Then, benzyloxyacetyl chloride (610 µL, 3.9 mmol) was 
carefully added and the resulting clear solution was stirred for 5 min at –
78 °C and 1.5 h at room temperature. The reaction mixture was cooled 
with an ice bath and quenched with sat NH4Cl (1.5 mL). This mixture was 
extracted with CH2Cl2 (3 ´ 15 mL) and the combined organic extracts were 
washed with 0.5 M NaOH (3 ́  25 mL) and brine (30 mL), dried over MgSO4 
and filtered. The solvent was removed in vacuo and the crude was purified 
by flash column chromatography (from hexanes/EtOAc 90:10 to 70:30) to 
give 684 mg (2.33 mmol, 78% yield) of 4 as a yellow oil. Rf (hexanes/EtOAc 
70:30) = 0.60. [α]D20 = +234 (c = 1.10, CHCl3). IR (ATR) n = 3059, 3025, 
2959, 2872, 1701, 1463, 1363, 1307, 1260 cm–1. 1H NMR (CDCl3, 400 
MHz) d = 7.42–7.28 (5H, m), 5.18 (1H, ddd, J = 8.1, 6.4, 1.0 Hz), 5.05 (1H, 
d, J = 17.7 Hz), 4.97 (1H, d, J = 17.7 Hz), 4.67 (1H, d, J = 11.6 Hz), 4.63 
(1H, d, J = 11.6 Hz), 3.59 (1H, dd, J = 11.5, 8.1 Hz), 3.08 (1H, dd, J = 11.5, 
1.0 Hz), 2.45–2.32 (1H, m), 1.07 (3H, d, J = 6.8 Hz), 0.99 (3H, d, J = 6.9 
Hz). 13C NMR (CDCl3, 100.6 MHz) d = 202.1 (C), 171.0 (C), 137.2 (C), 
128.4 (CH), 128.0 (CH), 127.9 (CH), 73.4 (CH2), 72.0 (CH2), 71.3 (CH), 
31.4 (CH2), 30.7 (CH), 19.0 (CH3), 17.6 (CH3). HRMS (+ESI): m/z calcd for 
[M+H]+ C15H20NO2S2: 310.0930, found: 310.0930. 
(S)-4-Isopropyl-N-(2-methoxyacetyl)-1,3-thiazolidine-2-thione (5):[16] 
An 1.55 M solution of n-BuLi in hexanes (2.1 mL, 3.3 mmol) was added 
dropwise to a solution of (S)-4-isopropyl-1,3-thiazolidine-2-thione (484 mg, 
3.0 mmol) in THF (2 mL) at –78 °C under N2 and the reaction mixture was 
stirred for 15 min. Then, methoxyacetyl chloride (360 µL, 3.9 mmol) was 
carefully added and the resulting clear solution was stirred for 5 min at –
78 °C and 1.5 h at room temperature. The reaction mixture was cooled 
with an ice bath and quenched with sat NH4Cl (1.2 mL). This mixture was 
extracted with CH2Cl2 (3 ´ 20 mL) and the combined organic extracts were 
dried over MgSO4 and filtered. The solvent was removed in vacuo and the 
crude was purified by flash column chromatography (hexanes/EtOAc 95:5) 
to afford 625 mg (2.68 mmol, 89% yield) of 5 as a yellow oil. Rf 
(hexanes/EtOAc 95:5) = 0.30. [α]D20 = +313 (c = 1.65, CHCl3). IR (ATR) n 
= 2963, 1709, 1368, 1313, 1264, 1176, 1120 cm–1. 1H NMR (CDCl3, 400 
MHz) d = 5.19 (1H, ddd, J = 8.2, 6.2, 1.2 Hz), 4.98 (1H, d, J = 17.7 Hz), 
4.87 (1H, d, J = 17.7 Hz), 3.61 (1H, dd, J = 11.6, 8.2 Hz), 3.48 (3H, s), 3.09 
(1H, dd, J = 11.6, 1.2 Hz), 2.44–2.33 (1H, m), 1.07 (3H, d, J = 6.7 Hz), 0.99 
(3H, d, J = 7.0 Hz). 13C NMR (CDCl3, 100.6 MHz) d = 202.1 (C), 171.0 (C), 
74.5 (CH2), 71.3 (CH), 59.3 (CH3), 31.5 (CH2), 30.7 (CH), 19.0 (CH3), 17.7 
(CH3).  
(S)-4-Isopropyl-N-(2-pivaloyloxyacetyl)-1,3-thiazolidine-2-thione 
(7):[16] A mixture of glycolic acid (1.52 g, 20 mmol) and pivaloyl chloride 
(4.4 mL, 36 mmol) was stirred at room temperature for 60 h under N2. Then, 
the volatiles were removed and the resulting O-pivaloylglycolic acid was 
used in the next step without further purification. 
A mixture of this acid, (S)-4-isopropyl-1,3-thiazolidine-2-thione (2.740 g, 
17.0 mmol), EDC·HCl (4.89 g, 25.5 mmol), and DMAP (104 mg, 0.85 
mmol) in CH2Cl2 (27 mL) was stirred at 0 °C for 15 min and at room 
temperature for 16 h under N2. It was diluted in Et2O (50 mL) and washed 
with 0.5 M HCl (3 ´ 40 mL), 0.5 M NaOH (3 ´ 40 mL), and brine (50 mL). 
The organic layer was dried over MgSO4 and concentrated. The residue 
was purified through flash chromatography (hexanes/EtOAc 90:10) to 
afford 4.11 g (13.5 mmol, 80% yield) of 7 as a yellow oil. Rf 
(hexanes/EtOAc 90:10) = 0.40. [a]D = +233 (c = 1.00, CHCl3). IR (film) n = 
2965, 2874, 1740, 1714, 1141 cm–1. 1H NMR (400 MHz, CDCl3) d = 5.44 
(2H, s), 5.11 (1H, ddd, J = 8.2, 5.9, 1.2 Hz), 3.63 (1H, dd, J = 11.6, 8.2 Hz), 
3.09 (1H, dd, J = 11.6, 1.2 Hz), 2.43–2.32 (1H, m), 1.27 (9H, s), 1.06 (3H, 
d, J = 6.8 Hz), 0.98 (3H, d, J = 7.0 Hz). 13C NMR (100.6 MHz, CDCl3) d = 
202.5 (C), 177.9 (C), 168.1 (C), 71.4 (CH), 65.0 (CH2), 38.7 (C), 31.4 (CH), 
30.7 (CH2), 27.1 (CH3), 19.0 (CH3), 17.5 (CH3). HRMS: m/z calcd for 
[M+H]+ C13H22NO3S2 304.1036, found 304.1037; m/z calcd for [M+Na]+ 
C13H21NNaO3S2 326.0855, found 326.0859.  







thiazolidine-2-thione. Neat TiCl4 (0.5 mL, 4.6 mmol) was added to a 
solution of 4 (707 mg, 2.3 mmol) in CH2Cl2 (18 mL) at room temperature 
under N2 and the reaction mixture was stirred for 30 min. The reaction was 
quenched by addition of sat NH4Cl (30 mL) and the layers were separated. 
The aqueous layer was extracted with CH2Cl2 (3 ´ 15 mL) and the 
combined organic extracts were dried over MgSO4, filtered and 
concentrated. The resulting N-acyl thioimide was used in the next step 
without further purification. 
Synthesis of (S)-N-acyl-4-isopropyl-1,3-thiazolidine-2-thiones 1, 2, 
and 6 
(S)-4-Isopropyl-N-(2-triethylsilyloxyacetyl)-1,3-thiazolidine-2-thione 
(1):[16] A solution of the deprotected N-acyl thioimide, TESOTf (0.65 mL, 
2.9 mmol, 1.25 equiv), and 2,6-lutidine (0.35 mL, 3.0 mmol, 1.3 equiv) in 
CH2Cl2 (9.2 mL) was stirred at 0 °C for 5 min and 40 min at room 
temperature under N2. The reaction was quenched by addition of neat 
MeOH (2.5 mL). The resulting mixture was diluted in Et2O (30 mL). Then, 
it was washed with sat NaHCO3 (3 ´ 20 mL), sat KHSO4 (3 ´ 20 mL), and 
brine (40 mL), dried over MgSO4, filtered and concentrated. The residue 
was purified by flash column chromatography (hexanes/EtOAc 90:10) to 
give 234 mg (0.70 mmol, 30% overall yield) of 1 as a yellow oil. Rf 
(hexanes/EtOAc 90:10) = 0.35. [a]D = +180.5 (c = 0.67, CHCl3). IR (ATR) 
n = 2951, 2870, 1705, 1679, 1464, 1405, 1364, 1264, 1175, 1119 cm–1. 1H 
NMR (400 MHz, CDCl3) d = 5.18 (1H, ddd, J = 8.2, 6.2, 1.2 Hz), 5.16 (1H, 
d, J = 18.2 Hz), 5.10 (1H, d, J = 18.2 Hz), 3.59 (1H, dd, J = 11.5, 8.2 Hz), 
3.08 (1H, dd, J = 11.5, 1.2 Hz), 2.45–2.33 (1H, m), 1.06 (3H, d, J = 6.8 Hz), 
0.98 (3H, d, J = 7.1 Hz), 0.98 (9H, t, J = 7.8 Hz), 0.66 (6H, q, J = 7.8 Hz). 
13C NMR (100.6 MHz, CDCl3) d = 202.0 (C), 172.8 (C), 71.6 (CH), 66.3 
(CH2), 31.4 (CH2), 30.7 (CH), 19.0 (CH3), 17.5 (CH3), 6.7 (CH3), 4.4 (CH2). 
(S)-N-(2-tert-Butyldimethylsilyloxyacetyl)-4-isopropyl-1,3-
thiazolidine-2-thione (2):[16] A solution of the deprotected N-acyl 
thioimide, TBSOTf (0.65 mL, 2.9 mmol, 1.25 equiv), and 2,6-lutidine (0.35 
mL, 3.0 mmol, 1.3 equiv) in CH2Cl2 (9.2 mL) was stirred at 0 °C for 5 min 
and 40 min at room temperature under N2. The reaction was quenched by 
addition of neat MeOH (2.5 mL). The resulting mixture was diluted in Et2O 
(30 mL). Then, it was washed with sat NaHCO3 (3 ´ 20 mL), sat KHSO4 (3 
´ 20 mL), and brine (40 mL), dried over MgSO4, filtered and concentrated. 
The residue was purified by flash column chromatography 
(hexanes/EtOAc 95:5) to give 391 mg (1.17 mmol, 51% overall yield) of 2 
as a yellow oil. Rf (hexanes/EtOAc 95:5) = 0.20. [a]D = +227 (c = 0.98, 
CHCl3). IR (ATR) n = 2958, 2857, 1715, 1373, 1263, 1178, 1142 cm–1. 1H 
NMR (400 MHz, CDCl3) d = 5.17 (1H, ddd, J = 8.2, 6.0, 1.2 Hz), 5.14 (1H, 
d, J = 18.3 Hz), 5.13 (1H, d, J = 18.3 Hz), 3.59 (1H, dd, J = 11.5, 8.2 Hz), 
3.08 (1H, dd, J = 11.5, 1.2 Hz), 2.43–2.35 (1H, m), 1.06 (3H, d, J = 6.8 Hz), 
0.98 (3H, d, J = 6.9 Hz), 0.93 (9H, s), 0.12 (3H, s), 0.11 (3H, s). 13C NMR 
(100.6 MHz, CDCl3) d = 202.9 (C), 172.9 (C), 71.6 (CH), 66.7 (CH2), 31.4 
(CH2), 30.7 (CH), 25.8 (CH3), 19.0 (CH3), 18.5 (C), 17.5 (CH3), –5.3 (CH3), 
–5.4 (CH3). 
(S)-N-(2-Benzoyloxyacetyl)-4-isopropyl-1,3-thiazolidine-2-thione 
(6):[16] A solution of the deprotected N-acyl thioimide, benzoyl chloride (1.3 
mL, 11.4 mmol, 5 equiv), and 2,6-lutidine (1.3 mL, 11.4 mmol, 5 equiv) in 
CH2Cl2 (9.2 mL) was stirred at 0 °C for 5 min and 40 min at room 
temperature under N2.The reaction was quenched by addition of neat 
MeOH (2.5 mL). The resulting mixture was diluted in Et2O (30 mL). Then, 
it was washed with sat NaHCO3 (3 ´ 20 mL), sat KHSO4 (3 ´ 20 mL), and 
brine (40 mL), dried over MgSO4, filtered and concentrated. The residue 
was purified by flash column chromatography (from CH2Cl2/hexanes 50:50 
to 80:20) to give 446 mg (1.38 mmol, 60% overall yield) of 6 as a yellow 
solid. Mp 93–95 °C. Rf (CH2Cl2/hexanes 80:20) = 0.40. [a]D = +212 (c = 
1.10, CHCl3). IR (KBr) n = 2960, 2870, 1726, 1376, 1260, 1183, 1115 cm–
1. 1H NMR (400 MHz, CDCl3) d = 8.12–8.09 (2H, m), 7.61–7.43 (3H, m), 
5.75 (1H, d, J = 16.7 Hz), 5.68 (1H, d, J = 16.7 Hz), 5.14 (1H, ddd, J = 8.2, 
5.9, 1.2 Hz), 3.66 (1H, dd, J = 11.6, 8.2 Hz), 3.11 (1H, dd, J = 11.6, 1.2 
Hz), 2.45–2.34 (1H, m), 1.08 (3H, d, J = 6.7 Hz), 0.98 (3H, d, J = 6.9 Hz). 
13C NMR (100.6 MHz, CDCl3) d = 202.5 (C), 167.9 (C), 166.0 (C), 133.3 
(CH), 129.9 (CH), 129.3 (C), 128.4 (CH), 71.5 (CH), 65.6 (CH2), 31.5 (CH2), 
30.7 (CH), 19.0 (CH3), 17.5 (CH3).  
General procedure for the direct Ni(II)-catalyzed addition of N-
glycolyl thiazolidinethiones to acetals 
Solid (Me3P)2NiCl2 was added to a solution of a N-glycolyl thioimide (0.50 
mmol) and a dimethyl acetal in CH2Cl2 (1.0 mL) under N2. The resulting 
mixture was cooled to –20 ºC and TESOTf and 2,6-lutidine (88 µL, 0.75 
mmol, 1.5 equivalents) were added dropwise after 3 and 7 min respectively. 
The reaction mixture was stirred at –20 ºC for 15 h. It was quenched with 
sat NH4Cl (1.2 mL) and then diluted in H2O (20 mL). The aqueous layer 
was extracted with CH2Cl2 (3 × 20 mL). The combined organic layers were 
washed with brine (50 mL), dried over MgSO4 and filtered. The solvent was 
removed in vacuo and the crude was purified by flash column 
chromatography to give the desired product. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-3-(4-methoxyphenyl)-2-
triethylsilyloxypropanoyl]-1,3-thiazolidine-2-thione (8a): The reaction 
was carried out as described in General Procedure using (Me3P)2NiCl2 (3.5 
mg, 12.5 µmol, 2.5 mol%), (S)-4-isopropyl-N-(2-triethylsilyloxyacetyl)-1,3-
thiazolidine-2-thione (1, 167 mg, 0.5 mmol), 4-methoxybenzaldehyde 
dimethyl acetal (a, 94 µL, 0.55 mmol), and TESOTf (130 µL, 0.58 mmol). 
The crude was purified by column chromatography (from hexanes/CH2Cl2 
50:50 to CH2Cl2) to give 46 mg (0.13 mmol, 26% yield) of 8a as a yellow 
oil. Rf (hexanes/CH2Cl2 20:80) = 0.60. [α]D20 = +138 (c = 1.00, CHCl3). IR 
(ATR) n = 2951, 2870, 1694, 1605, 1509, 1360, 1238, 1156, 1108 cm–1. 
1H NMR (CDCl3, 400 MHz) d = 7.39–7.37 (2H, m), 6.89–6.87 (2H, m), 6.70 
(1H, J = 8.1 Hz), 5.36 (1H, ddd, J = 8.0, 6.4, 0.9 Hz), 4.27 (1H, d, J = 8.1 
Hz), 3.81 (3H, s), 3.50 (1H, dd, J = 11.5, 8.0 Hz), 3.10 (3H, s), 3.03 (1H, 
dd, J = 11.5, 0.9 Hz), 2.40–2.31 (1H, m), 1.11 (3H, d, J = 6.8 Hz), 1.03 (3H, 
d, J = 6.9 Hz), 0.70 (9H, t, J = 7.9 Hz), 0.39–0.22 (6H, m). 13C NMR (CDCl3, 
100.6 MHz) d = 202.6 (C), 174.8 (C), 159.6 (C), 131.0 (C), 129.7 (CH), 
113.4 (CH), 86.8 (CH), 71.8 (CH), 71.3 (CH), 56.6 (CH3), 55.3 (CH3), 30.6 
(CH), 30.5 (CH2), 18.9 (CH3), 17.8 (CH3), 6.4 (CH3), 4.4 (CH2). HRMS 
(+ESI): m/z cald for [M–OCH3]+ C22H34NO3S2Si: 452.1744, found: 
452.1733; m/z calcd for [M+NH4]+C23H41N2O4S2Si: 501.2272, found: 




(9a): The reaction was carried out as described in General Procedure 
using (Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 2.5 mol%), (S)-N-(tert-
butyldimethylsilyloxyacetyl)-4-isopropyl-1,3-thiazolidine-2-thione (2, 167 
mg, 0.5 mmol), 4-methoxybenzaldehyde dimethyl acetal (a, 94 µL, 0.55 
mmol), and TBSOTf (133 µL, 0.58 mmol). The crude was purified by 
column chromatography (from hexanes/CH2Cl2 50:50 to 40:60) to give 117 
mg (0.25 mmol, 49% yield) of 9a as a yellow oil. Rf (CH2Cl2) = 0.65. [α]D20 
= +141 (c = 0.96, CHCl3). IR (film) n = 2930, 2858, 1704, 1512, 1364, 1250, 
1163, 1121 cm–1. 1H NMR (CDCl3, 400 MHz) d = 7.39–7.37 (2H, m), 6.89–
6.87 (2H, m), 6.75 (1H, d, J = 8.1 Hz), 5.39 (1H, ddd, J = 8.1, 6.2, 1.2 Hz), 
4.26 (1H, d, J = 8.1 Hz), 3.81 (3H, s), 3.50 (1H, dd, J = 11.5, 8.1 Hz), 3.10 
(3H, s), 3.03 (1H, dd, J = 11.5, 1.2 Hz), 2.42–2.30 (1H, m), 1.11 (3H, d, J 
= 6.8 Hz), 1.03 (3H, d, J = 6.9 Hz), 0.72 (9H, s), –0.22 (3H, s), –0.39 (3H, 
s). 13C NMR (CDCl3, 100.6 MHz) d = 202.6 (C), 174.8 (C), 159.6 (C), 131.0 
(C), 129.8 (CH), 113.4 (CH), 86.9 (CH), 71.8 (CH), 71.7 (CH), 56.6 (CH3), 
55.3 (CH3), 30.6 (CH), 30.4 (CH2), 25.5 (CH3), 18.9 (CH3), 17.9 (C), 17.7 
(CH3), –5.2 (CH3), –5.4 (CH3). HRMS (+ESI): m/z calcd for [M–OMe]+ 






C22H34NO3S2Si: 452.1744, found: 452.1741, calcd for [M+Na]+ 
C23H37NNaO4S2Si: 506.1825, found:506.1825. 
(S)-N-[(2R,3R)-2-(tert-Butyldiphenylsilyloxy)-3-methoxy-3-(4-
methoxyphenyl)propanoyl]-4-isopropyl-1,3-thiazolidine-2-thione 
(10a): The reaction was carried out as described in General Procedure 
using (Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 2.5 mol%), (S)-N-(tert-
butyldiphenylsilyloxyacetyl)-4-isopropyl-1,3-thiazolidine-2-thione (3, 229 
mg, 0.5 mmol), 4-methoxybenzaldehyde dimethyl acetal (a, 94 µL, 0.55 
mmol), and TESOTf (130 µL, 0.58 mmol). The crude was purified by 
column chromatography (hexanes/CH2Cl2 60:40) to give 58 mg (0.10 
mmol, 19% yield) of 10a as a yellow oil. Rf (hexanes/CH2Cl2 60:40) = 0.45. 
[α]D20 = +119 (c = 0.90, CHCl3). IR (ATR) n = 2955, 2925, 2851, 1694, 
1609, 1505, 1360, 1234, 1164, 1112 cm–1. 1H NMR (CDCl3, 400 MHz) d = 
7.62–7.60 (2H, m), 7.48–7.45 (2H, m), 7.42–7.29 (4H, m), 7.16–7.12 (2H, 
m), 7.00–6.98 (2H, m), 6.95–6.93 (2H, m), 6.80 (1H, d, J = 7.6 Hz), 4.71 
(1H, ddd, J = 8.3, 5.7, 1.2 Hz), 4.36 (1H, d, J = 7.6 Hz), 3.87 (3H, s), 3.09 
(3H, s), 2.78 (1H, dd, J = 11.2, 8.3 Hz), 2.67 (1H, dd, J = 11.2, 1.2 Hz), 
2.20–2.12 (1H, m), 0.95 (3H, d, J = 6.8 Hz), 0.93 (9H, s), 0.90 (3H, d, J = 
7.0 Hz). 13C NMR (CDCl3, 100.6 MHz) d = 201.6 (C), 174.06 (C), 159.8 (C), 
136.1 (CH), 135.7 (CH), 133.3 (C), 132.5 (C), 131.1 (C), 130.1 (CH), 129.7 
(CH), 129.4 (CH), 127.3 (CH), 127.2 (CH), 113.6 (CH), 87.4 (CH), 72.0 
(CH), 71.2 (CH), 56.5 (CH3), 55.3 (CH3), 30.4 (CH), 29.2 (CH2), 26.8 (CH3), 
19.0 (C), 18.8 (CH3), 17.1 (CH3). HRMS (+ESI): m/z calcd for [M–OCH3]+ 
C32H38NO3S2Si: 576.2057, found: 576.2052; m/z calcd for [M+Na]+ 
C33H41NNaO4S2Si: 630.2138, found: 630.2141. 
(S)-N-[(2R,3R)-2-Benzyloxy-3-methoxy-3-(4-
methoxyphenyl)propanoyl]-4-isopropyl-1,3-thiazolidine-2-thione 
(11a): The reaction was carried out as described in General Procedure 
using (Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 2.5 mol%), (S)-N-benzyloxyacetyl-
4-isopropyl-1,3-thiazolidine-2-thione (4, 155 mg, 0.5 mmol), 4-
methoxybenzaldehyde dimethyl acetal (a, 94 µL, 0.55 mmol), and TESOTf 
(130 µL, 0.58 mmol). The crude was purified by column chromatography 
(from hexanes/CH2Cl2 30:70 to CH2Cl2) to give 142 mg (0.31 mmol, 61% 
yield) of 11a as a yellow oil. Rf (CH2Cl2) = 0.50. [α]D20 = +151 (c = 1.00, 
CHCl3). IR (ATR) n = 2959, 2925, 2866, 1694, 1606, 1509, 1245, 1168, 
1093, 1027 cm–1. 1H NMR (CDCl3, 400 MHz)  d = 7.44–7.41 (2H, m), 7.26–
7.24 (3H, m), 7.14–7.12 (2H, m), 6.92–6.90 (2H, m), 6.54 (1H, d, J = 8.2 
Hz), 5.03 (1H, ddd, J = 8.1, 6.1, 1.1 Hz), 4.40 (1H, d, J = 12.1 Hz), 4.37 
(1H, d, J = 8.2 Hz), 4.17 (1H, d, J = 12.1 Hz), 3.84 (3H, s), 3.18 (1H, dd, J 
= 11.3, 8.1 Hz), 3.10 (3H, s), 2.88 (1H, dd, J = 11.3, 1.1 Hz), 2.30–2.22 
(1H, m), 1.03 (3H, d, J = 6.8 Hz), 0.96 (3H, d, J = 6.9 Hz). 13C NMR (CDCl3, 
100.6 MHz) d = 202.6 (C), 173.5 (C), 159.6 (C), 137.4 (C), 130.7 (C), 129.6 
(CH), 128.4 (CH), 128.1 (CH), 127.8 (CH), 113.6 (CH), 85.0 (CH), 78.1 
(CH), 73.7 (CH2), 71.5 (CH), 56.6 (CH3), 55.2 (CH3), 30.5 (CH), 30.3 (CH2), 
18.8 (CH3), 17.5 (CH3); HRMS (+ESI): m/z calcd for [M–OCH3]+ 
C23H26NO3S2: 428.1349, found: 428.1346; m/z calcd for [M+Na]+ 
C24H29NNaO4S2: 482.1430, found: 482.1425. 
(S)-N-[(2R,3R)-2,3-Dimethoxy-3-(4-methoxyphenyl)propanoyl]-4-
isopropyl-1,3-thiazolidine-2-thione (12a): The reaction was carried out 
as described in General Procedure using (Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 
2.5 mol%), (S)-4-isopropyl-N-methoxyacetyl-1,3-thiazolidine-2-thione (5, 
117 mg, 0.5 mmol), 4-methoxybenzaldehyde dimethyl acetal (a, 94 µL, 
0.55 mmol), and TESOTf (130 µL, 0.58 mmol). The crude was purified by 
column chromatography (from hexanes/CH2Cl2 40:60 to CH2Cl2) to give 
70 mg (0.18 mmol, 36% yield) of 12a as a yellow oil. Rf (CH2Cl2) = 0.40. 
[α]D20 = +161 (c = 1.04, CHCl3). IR (ATR) n = 2959, 2929, 2821, 1690, 
1608, 1509, 1360, 1238, 1160, 1093 cm–1. 1H NMR (CDCl3, 400 MHz) d = 
7.39–7.37 (2H, m), 6.91–6.89 (2H, m), 6.48 (1H, d, J = 7.7 Hz), 5.39 (1H, 
ddd, J = 8.5, 5.5, 1.2 Hz), 4.37 (1H, d, J = 7.7 Hz), 3.81 (3H, s), 3.53 (1H, 
dd, J = 11.5, 8.5 Hz), 3.15 (3H, s), 3.11 (3H, s), 3.04 (1H, dd, J = 11.5, 1.2 
Hz), 2.38–2.26 (1H, m), 1.11 (3H, d, J = 6.8 Hz), 1.10 (3H, d, J = 6.9 Hz). 
13C NMR (CDCl3, 100.6 MHz) d = 202.9 (C), 173.3 (C), 159.6 (C), 130.3 
(C), 129.6 (CH), 113.6 (CH), 84.7 (CH), 80.4 (CH), 71.8 (CH), 58.8 (CH3), 
56.4 (CH3), 55.2 (CH3), 30.6 (CH), 29.8 (CH2), 19.0 (CH3), 17.2 (CH3). 
HRMS (+ESI): m/z calcd for [M–OCH3]+ C17H22NO3S2: 352.1036, found: 




(13a): The reaction was carried out as described in General Procedure 
using (Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 2.5 mol%), (S)-N-
benzoyloxyacetyl-4-isopropyl-1,3-thiazolidine-2-thione (6, 162 mg, 0.5 
mmol), 4-methoxybenzaldehyde dimethyl acetal (94 µL, 0.55 mmol) and 
TESOTf (130 µL, 0.58 mmol). The crude was purified by column 
chromatography (hexanes/CH2Cl2 40:60) to give 173 mg (0.37 mmol, 73% 
yield) of 13a as a yellow oil. Rf (hexanes/CH2Cl2 20:80) = 0.60. [α]D20 = 
+129 (c = 0.93, CHCl3). IR (ATR) n = 2962, 2925, 2825, 1716, 1694, 1605, 
1512, 1449, 1360, 1245, 1171, 1108, 1090, 1026 cm–1. 1H NMR (CDCl3, 
400 MHz) d = 7.93–7.90 (2H, m), 7.55–7.46 (3H, m), 7.43 (1H, d, J = 7.4 
Hz), 7.41–7.37 (2H, m), 6.94–6.92 (2H, m), 5.32 (1H, ddd, J = 8.1, 6.0, 1.0 
Hz), 4.75 (1H, d, J = 7.4 Hz), 3.81 (3H, s), 3.65 (1H, dd, J = 11.5, 8.1 Hz), 
3.21 (3H, s), 3.04 (1H, dd, J = 11.5, 1.0 Hz), 2.41–2.29 (1H, m), 1.13 (3H, 
d, J = 6.8 Hz), 1.03 (3H, d, J = 7.0 Hz). 13C NMR (CDCl3, 100.6 MHz) d = 
202.8 (C), 170.2 (C), 165.8 (C), 159.8 (C), 133.3 (CH), 129.8 (CH), 129.5 
(C), 129.5 (CH), 129.0 (C), 128.3 (CH), 113.7 (CH), 83.5 (CH), 73.6 (CH), 
71.7 (CH), 56.8 (CH3), 55.2 (CH3), 30.5 (CH), 30.5 (CH2), 18.9 (CH3), 17.6 
(CH3). HRMS (+ESI): m/z calcd for [M–OCH3]+ C23H24NO4S2: 442.1141, 
found: 442.1134; m/z calcd for [M+Na]+ C24H27NNaO5S2: 496.1223, found: 
496.1224. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-3-(4-methoxyphenyl)-2-
pivaloyloxypropanoyl]-1,3-thiazolidine-2-thione (14a): The reaction 
was carried out as described in General Procedure using (Me3P)2NiCl2 (3.5 
mg, 12.5 µmol, 2.5 mol%), (S)-4-isopropyl-N-pivaloyloxyacetyl-1,3-
thiazolidine-2-thione (7, 152 mg, 0.5 mmol), 4-methoxybenzaldehyde 
dimethyl acetal (a, 94 µL, 0.55 mmol), and TESOTf (130 µL, 0.58 mmol). 
The crude was purified by column chromatography (hexanes/EtOAc 
85:15) to give 175 mg (0.39 mmol, 77% yield) of 14a as a yellow solid. Mp 
129–130 ºC. Rf (hexanes/EtOAc 85:15) = 0.40. [α]D20 = +172 (c = 1.00, 
CHCl3). IR (ATR) n = 2966, 2929, 2862, 2825, 1727, 1701, 1606, 1512, 
1360, 1245, 1171, 1145 cm–1. 1H NMR (CDCl3, 400 MHz) d = 7.39–7.37 
(2H, m), 7.13 (1H, d, J = 7.4 Hz), 6.90–6.88 (2H, m), 5.29 (1H, ddd, J = 
8.3, 5.9, 1.0 Hz), 4.60 (1H, d, J = 7.4 Hz), 3.81 (3H, s), 3.60 (1H, dd, J = 
11.4, 8.3 Hz), 3.17 (3H, s), 3.01 (1H, dd, J = 11.4, 1.0 Hz), 2.36–2.27 (1H, 
m), 1.11 (3H, d, J = 6.8 Hz), 1.10 (9H, s), 1.01 (3H, d, J = 6.9 Hz). 13C NMR 
(CDCl3, 100.6 MHz) d = 202.6 (C), 177.5 (C), 170.3 (C), 159.7 (C), 129.4 
(CH), 129.4 (C), 113.5 (CH), 83.4 (CH), 73.1 (CH), 71.6 (CH), 56.7 (CH3), 
55.2 (CH3), 38.3 (C), 30.5 (CH), 30.2 (CH2), 26.8 (CH3), 18.9 (CH3), 17.4 
(CH3). HRMS (+ESI): m/z calcd for [M–OCH3]+ C21H28NO4S2: 422.1454, 




The reaction was carried out as described in General Procedure using 
(Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 2.5 mol%), 7 (152 mg, 0.5 mmol), 
piperonal dimethyl acetal (b, 108 mg, 0.55 mmol), and TESOTf (130 µL, 
0.58 mmol). The crude was purified by column chromatography (from 
hexanes/EtOAc 88:12 to 84:16) to give 186 mg (0.40 mmol, 79% yield) of 
14b as a yellow solid. Mp 132–133 ºC. Rf (hexanes/EtOAc 80:20) = 0.45. 
[α]D20 = +187 (c = 1.25, CHCl3). IR (ATR) n = 2959, 2925, 2870, 1724, 
1705, 1480, 1438, 1337, 1249, 1156, 1030 cm–1. 1H NMR (CDCl3, 400 
MHz) d = 7.11 (1H, d, J = 7.4 Hz), 7.03 (1H, d, J = 1.6 Hz), 6.86 (1H, dd, J 
= 7.9, 1.6 Hz), 6.77 (1H, d, J = 7.9 Hz), 5.98–5.95 (2H, m), 5.29 (1H, ddd, 






J = 8.3, 5.9, 1.0 Hz), 4.57 (1H, d, J = 7.4 Hz), 3.60 (1H, dd, J = 11.5, 8.3 
Hz), 3.18 (3H, s), 3.02 (1H, dd, J = 11.5, 1.0 Hz), 2.37–2.25 (1H, m), 1.12 
(9H, s), 1.09 (3H, d, J = 6.9 Hz), 1.01 (3H, d, J = 6.9 Hz). 13C NMR (CDCl3, 
100.6 MHz) d = 202.6 (C), 177.5 (C), 170.1 (C), 147.7 (2 × C), 131.3 (C), 
122.1 (CH), 108.1 (CH), 107.6 (CH), 101.0 (CH2), 83.6 (CH), 72.9 (CH), 
71.6 (CH), 56.7 (CH3), 38.3 (C), 30.5 (CH), 30.2 (CH2), 26.8 (CH3), 18.8 
(CH3), 17.4 (CH3). HRMS (+ESI): m/z calcd for [M–OCH3]+ C21H26NO5S2: 
436.1247, found: 436.1247. 
(S)-N-[(2R,3R)-3-(4-Dimethylaminophenyl)-3-methoxy-2-
pivaloyloxypropanoyl]-4-isopropyl-1,3-thiazolidine-2-thione (14c): 
The reaction was carried out as described in General Procedure using 
(Me3P)2NiCl2 (7.0 mg, 25 µmol, 5 mol%), 7 (152 mg, 0.5 mmol), 4-
dimethylaminobenzaldehyde dimethyl acetal (c, 107 mg, 0.55 mmol), and 
TESOTf (249 µL, 1.10 mmol). The crude was purified by column 
chromatography (from hexanes/EtOAc 90:10 to 80:20) to give 172 mg 
(0.37 mmol, 74% yield) of 14c as a yellow solid. Mp 136–137 ºC. Rf 
(hexanes/EtOAc 80:20) = 0.45. [α]D20 = +165 (c = 1.00, CHCl3). IR (ATR) 
n = 2973, 2954, 2870, 1720, 1702, 1613, 1523, 1360, 1182, 1149 cm–1. 1H 
NMR (CDCl3, 400 MHz) d = 7.32–7.30 (2H, m), 7.13 (1H, d, J = 7.4 Hz), 
6.71–6.69 (2H, m), 5.30 (1H, ddd, J = 8.4, 5.7, 1.0 Hz), 4.54 (1H, d, J = 7.4 
Hz), 3.59 (1H, dd, J = 11.4, 8.4 Hz), 3.16 (3H, s), 3.00 (1H, dd, J = 11.4, 
1.0 Hz), 2.96 (6H, s), 2.37–2.26 (1H, m), 1.11 (3H, d, J = 6.6 Hz), 1.11 (9H, 
s), 1.01 (3H, d, J = 6.9 Hz), 13C NMR (CDCl3, 100.6 MHz) d = 202.4 (C), 
177.6 (C), 170.5 (C), 150.5 (C), 129.1 (CH), 124.8 (C), 111.8 (CH), 83.7 
(CH), 73.3 (CH), 71.6 (CH), 56.5 (CH3), 40.4 (CH3), 38.3 (C), 30.5 (CH), 
30.1 (CH2), 26.8 (CH3), 18.9 (CH3), 17.4 (CH3) HRMS (+ESI): m/z calcd 
for [M–OCH3]+ C22H31N2O3S2: 435.1771, found: 435.1784; m/z calcd for 
[M+H]+ C23H35N2O4S2: 467.2033, found: 467.2047. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-2-pivaloyloxy-3-(4-
tolyl)propanoyl]-1,3-thiazolidine-2-thione (14d): The reaction was 
carried out as described in General Procedure using (Me3P)2NiCl2 (7.0 mg, 
25 µmol, 5 mol%), 7 (152 mg, 0.5 mmol), 4-methylbenzaldehyde dimethyl 
acetal (d, 91 mg, 0.55 mmol), and TESOTf (249 µL, 1.10 mmol). The crude 
was purified by column chromatography (from hexanes/CH2Cl2 50:50 to 
10:90) to give 145 mg (0.33 mmol, 66% yield) of 14d as a yellow solid. Mp 
139–140 ºC. Rf (hexanes/CH2Cl2 10:90) = 0.60. [α]D20 = +196 (c = 0.75, 
CHCl3). IR (ATR) n = 2959, 2928, 1724, 1694, 1464, 1357, 1305, 1257, 
1171, 1145 cm–1. 1H NMR (CDCl3, 400 MHz) d = 7.35–7.33 (2H, m), 7.17–
7.15 (2H, m), 7.12 (1H, d, J = 7.3 Hz), 5.29 (1H, ddd, J = 8.4, 5.6, 1.1 Hz), 
4.62 (1H, d, J = 7.3 Hz), 3.59 (1H, dd, J = 11.4, 8.4 Hz), 3.18 (3H, s), 3.01 
(1H, dd, J = 11.4, 1.1 Hz), 2.37–2.28 (1H, m), 2.35 (3H, s), 1.11 (3H, d, J 
= 7.0 Hz), 1.10 (9H, s), 1.02 (3H, d, J = 6.9 Hz). 13C NMR (CDCl3, 100.6 
MHz) d = 202.5 (C), 177.5 (C), 170.2 (C), 138.2 (C), 134.3 (C), 128.8 (CH), 
128.1 (CH), 83.6 (CH), 73.1 (CH), 71.6 (CH), 56.8 (CH3), 38.3 (C), 30.5 
(CH), 30.2 (CH2), 26.8 (CH3), 21.2 (CH3), 18.9 (CH3), 17.4 (CH3); HRMS 
(+ESI): m/z calcd for [M+H]+ C22H32NO4S2: 438.1767, found: 438.1772; 
m/z calcd for [M+Na]+ C22H31NNaO4S2: 460.1587, found: 460.1595. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-3-phenylpropanoyl-2-
pivaloyloxy]-1,3-thiazolidine-2-thione (14e):[16] The reaction was carried 
out as described in General Procedure using (Me3P)2NiCl2 (7.0 mg, 25 
µmol, 5 mol%), 7 (152 mg, 0.5 mmol), benzaldehyde dimethyl acetal (e, 
83 µL, 0.55 mmol), and TESOTf (249 µL, 1.10 mmol). The crude was 
purified by column chromatography twice (first, from hexanes/EtOAc 93:7 
to 85:15; finally, from hexanes/CH2Cl2 70:30 to 15:85) to give 84 mg (0.20 
mmol, 40% yield) of 14e as a yellow solid. Mp 142–143 ºC. Rf 
(hexanes/EtOAc 85:15) = 0.45. [α]D20 = +211 (c = 1.15, CHCl3). IR (KBr) n 
= 2962, 1728, 1707, 1368, 1178, 1149 cm–1. 1H NMR (CDCl3, 400 MHz) d 
= 7.47–7.44 (2H, m), 7.38–7.30 (3H, m), 7.15 (1H, d, J = 7.6 Hz), 5.30 (1H, 
ddd, J = 8.3, 5.9, 1.0 Hz), 4.64 (1H, d, J = 7.6 Hz), 3.60 (1H, dd, J = 11.4, 
8.3 Hz), 3.20 (3H, s), 3.02 (1H, dd, J = 11.4, 1.0 Hz), 2.39–2.27 (1H, m), 
1.12 (3H, d, J = 6.8 Hz), 1.08 (9H, s), 1.02 (3H, d, J = 6.9 Hz). 13C NMR 
(CDCl3, 100.6 MHz) d = 202.6 (C), 177.5 (C), 170.3 (C), 137.5 (C), 128.5 
(CH), 128.2 (CH), 128.1 (CH), 83.9 (CH), 73.0 (CH), 71.7 (CH), 56.9 (CH3), 
38.3 (C), 30.6 (CH), 30.3 (CH2), 26.8 (CH3), 18.9 (CH3), 17.5 (CH3). HRMS 
(+ESI): m/z calcd for [M+H]+ C21H30NO4S2: 424.1611, found: 424.1625. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-3-(3-methoxyphenyl)-2-
pivaloyloxypropanoyl]-1,3-thiazolidine-2-thione (14f):[16] The reaction 
was carried out as described in General Procedure using (Me3P)2NiCl2 (7.0 
mg, 25 µmol, 5 mol%), 7 (152 mg, 0.5 mmol), 3-methoxybenzaldehyde 
dimethyl acetal (f, 100 mg, 0.55 mmol), and TESOTf (249 µL, 1.10 mmol). 
The crude was purified by column chromatography (hexanes/EtOAc 
85:15) to give 59 mg (0.13 mmol, 26% yield) of 14f as a yellow solid. Mp 
85–88 ºC. Rf (hexanes/EtOAc 85:15) = 0.35. [α]D20 = +247 (c = 0.90, 
CHCl3). IR (KBr) n = 3005, 2968, 2868, 1735, 1698, 1486, 1145, 1095 cm–
1. 1H NMR (CDCl3, 400 MHz) d = 7.28–7.22 (1H, m), 7.14 (1H, d, J = 7.6 
Hz), 7.14 (1H, dd, J = 2.6, 1.5 Hz), 7.02 (1H, dt, J = 7.6, 1.5 Hz), 6.86 (1H, 
ddd, J = 8.3, 2.6, 1.5 Hz), 5.30 (1H, ddd, J = 8.3, 5.9, 1.1 Hz), 4.61 (1H, d, 
J = 7.6 Hz), 3.82 (3H, s), 3.60 (1H, dd, J = 11.4, 8.3 Hz), 3.20 (3H, s), 3.02 
(1H, dd, J = 11.4, 1.1 Hz), 2.39–2.27 (1H, m), 1.12 (3H, d, J = 6.8 Hz), 1.10 
(9H, s), 1.02 (3H, d, J = 6.9 Hz). 13C NMR (CDCl3, 100.6 MHz) d = 202.6 
(C), 177.5 (C), 170.3 (C), 159.6 (C), 139.2 (C), 129.0 (CH), 120.7 (CH), 
114.5 (CH), 113.0 (CH), 83.9 (CH), 72.9 (CH), 71.7 (CH), 56.9 (CH3), 55.2 
(CH3), 38.3 (C), 30.5 (CH), 30.3 (CH2), 26.8 (CH3), 19.0 (CH3), 17.5 (CH3). 
HRMS (+ESI): m/z calcd for [M+H]+ C22H32NO5S2: 422.1454, found: 
422.1453; m/z calcd for [M+Na]+ C22H31NNaO5S2: 476.1536, found: 
476.1539. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-3-(2-methoxyphenyl)-2-
pivaloyloxypropanoyl]-1,3-thiazolidine-2-thione (14g): The reaction 
was carried out as described in General Procedure using (Me3P)2NiCl2 (7.0 
mg, 25 µmol, 5 mol%), 7 (152 mg, 0.5 mmol), 2-methoxybenzaldehyde 
dimethyl acetal (g, 100 mg, 0.55 mmol), and TESOTf (249 µL, 1.10 mmol). 
The crude was purified by column chromatography (from hexanes/CH2Cl2 
50:50 to 20:80) to give 120 mg (0.30 mmol, 60% yield) of 14g as a yellow 
solid. Mp 125–126 ºC. Rf (hexanes/CH2Cl2 20:80) = 0.45. [α]D20 = +143 (c 
= 1.00, CHCl3). IR (ATR) n = 2955, 2929, 2870, 1724, 1698, 1598, 1586, 
1486, 1457, 1360, 1264, 1242, 1160 cm–1. 1H NMR (CDCl3, 400 MHz) d = 
7.62 (1H, dd, J = 7.5, 1.8 Hz), 7.29 (1H, ddd, J = 8.3, 7.5, 1.8 Hz), 7.01 
(1H, td, J = 7.5, 1.1 Hz), 6.96 (1H, d, J = 5.8 Hz), 6.85 (1H, dd, J = 8.3, 1.1 
Hz), 5.43 (1H, d, J = 5.8 Hz), 5.16 (1H, ddd, J = 8.4, 5.3, 1.0 Hz), 3.78 (3H, 
s), 3.61 (1H, dd, J = 11.4, 8.4 Hz), 3.22 (3H, s), 3.01 (1H, dd, J = 11.4, 1.0 
Hz), 2.39–2.28 (1H, m), 1.11 (3H, d, J = 6.8 Hz), 1.08 (9H, s), 1.00 (3H, d, 
J = 7.0 Hz). 13C NMR (CDCl3, 100.6 MHz) d = 202.6 (C), 177.9 (C), 169.6 
(C), 157.8 (C), 129.5 (CH), 129.3 (CH), 125.0 (C), 120.5 (CH), 110.0 (CH), 
75.5 (CH), 73.4 (CH), 72.0 (CH), 56.9 (CH3), 55.3 (CH3), 38.5 (C), 30.8 
(CH), 30.1 (CH2), 26.8 (CH3), 19.0 (CH3), 17.2 (CH3). HRMS (+ESI): m/z 
calcd for [M+Na]+ C22H31NNaO5S2: 476.1536, found: 476.1536. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-5-phenyl-2-pivaloyloxy-4-
pentenoyl]-1,3-thiazolidine-2-thione (14h). The reaction was carried out 
as described in General Procedure using (Me3P)2NiCl2 (7.0 mg, 25 µmol, 
5 mol%), 7 (152 mg, 0.5 mmol), (E)-cinnamaldehyde dimethyl acetal (h, 
98 mg, 0.55 mmol), and TESOTf (136 µL, 0.60 mmol). The crude was 
purified by column chromatography (hexanes/CH2Cl2 30:70) to give 142 
mg (0.31 mmol, 63% yield) of 14h as a yellow oil. Rf (CH2Cl2) = 0.45. [α]D20 
= +197 (c = 1.00, CHCl3). IR (ATR) n = 2962, 2925, 2866, 1731, 1698, 
1475, 1460, 1360, 1260, 1175, 1145 cm–1. 1H NMR (CDCl3, 400 MHz) d = 
7.40–7.25 (5H, m), 6.96 (1H, d, J = 4.8 Hz), 6.60 (1H, d, J = 16.0 Hz), 6.25 
(1H, dd, J = 16.0, 8.4 Hz), 5.23 (1H, ddd, J = 8.4, 6.0, 1.1 Hz), 4.41 (1H, 
dd, J = 8.4, 4.8 Hz), 3.61 (1H, dd, J = 11.5, 8.4, Hz), 3.35 (3H, s), 3.01 (1H, 
dd, J = 11.5, 1.1 Hz), 2.31–2.19 (1H, m), 1.23 (9H, s),1.06 (3H, d, J = 6.8 
Hz), 0.94 (3H,d, J = 6.9 Hz). 13C NMR (CDCl3, 100.6 MHz) d = 202.4 (C), 
177.8 (C), 168.8 (C), 136.1 (C), 135.3 (CH), 128.6 (CH), 128.1 (CH), 126.7 
(CH), 124.6 (CH), 81.6 (CH), 73.5 (CH), 71.6 (CH), 56.8 (CH3), 38.7 (C), 






30.5 (CH), 30.5 (CH2), 27.0 (CH3), 18.9 (CH3), 17.5 (CH3). HRMS (+ESI): 
m/z calcd for [M–OCH3]+ C22H28NO3S2: 418.1505, found: 418.1518. 
(S)-4-Isopropyl-N-[(2R,3R)-3-methoxy-4-methyl-5-phenyl-2-
pivaloyloxy-4-pentenoyl]-1,3-thiazolidine-2-thione (14i): The reaction 
was carried out as described in General Procedure using (Me3P)2NiCl2 (3.5 
mg, 12.5 µmol, 2.5 mol%), 7 (152 mg, 0.5 mmol), (E)-a-
methylcinnamaldehyde dimethyl acetal (i, 106 mg, 0.55 mmol), and 
TESOTf (130 µL, 0.58 mmol). The crude was purified by column 
chromatography (hexanes/EtOAc 92:8) to give 203 mg (0.45 mmol, 89% 
yield) of 14i as a yellow oil. Rf (hexanes/EtOAc 85:15) = 0.45. [α]D20 = +222 
(c = 2.10, CHCl3). IR (film) n = 2966, 2874, 1732, 1700, 1364, 1176, 
1149cm–1. 1H NMR (CDCl3, 400 MHz) d = 7.37–7.19 (5H, m), 7.20 (1H, d, 
J = 7.5 Hz), 6.54 (1H, br s), 5.31 (1H, ddd, J = 8.5, 5.7, 1.1 Hz), 4.26 (1H, 
d, J = 7.5 Hz), 3.57 (1H, dd, J = 11.5, 8.5 Hz), 3.25 (3H, s), 2.99 (1H, dd, 
J = 11.5, 1.1 Hz), 2.32–2.22 (1H, m), 1.66 (3H, d, J = 1.3 Hz), 1.19 (9H, s), 
1.05 (3H, d, J = 6.8 Hz), 0.96 (3H,d, J = 6.9 Hz). 13C NMR (CDCl3, 100.6 
MHz) d = 202.5 (C), 177.6 (C), 170.3 (C), 136.8 (C), 134.5 (C), 131.4 (CH), 
128.9 (CH), 128.1 (CH), 126.8 (CH), 87.5 (CH), 71.6 (CH), 70.8 (CH), 56.3 
(CH3), 38.4 (C), 30.5 (CH), 29.9 (CH2), 26.9 (CH3), 18.8 (CH3), 17.1 (CH3), 
13.2 (CH3). HRMS (+ESI): m/z calcd for [M+Na]+ 
C24H33NNaO4S2:486.1744, found: 486.1742. 
(S)-N-[(2R,3R)-Hexacarbonyl[µ-η4-(3-ethoxy-2-pivaloyloxy-4-
pentynoyl)dicobalt(Co-Co)]-4-isopropyl-1,3-thiazolidine-2-thione 
(14j): The reaction was carried out as described in General Procedure 
using (Me3P)2NiCl2 (7.0 mg, 25 µmol, 5 mol%), 7 (152 mg, 0.5 mmol), 
hexacarbonyl μ-[η4-(1,1-diethoxypropyne)]dicobalt (j, 311 mg, 0.75 mmol), 
and TESOTf (249 µL, 1.10 mmol). The crude was purified by column 
chromatography (hexanes/EtOAc 90:10) to give 264 mg (0.39 mmol, 79% 
yield) of 14j as a deep maroon solid. Mp 115–116 ºC. Rf (hexanes/EtOAc 
90:10) = 0.35. IR (ATR) n = 2962, 2870, 2091, 2046, 2017, 1998, 1720, 
1683, 1357, 1283, 1179, 1134, 1090 cm–1. 1H NMR (CDCl3, 400 MHz) d = 
6.84 (1H, d, J = 7.8 Hz), 6.02 (1H, d, J = 0.8 Hz), 5.20 (1H, ddd, J = 8.1, 
5.9, 0.9 Hz), 4.98 (1H, dd, J = 7.8, 0.8 Hz), 3.81 (1H, dq, J = 8.6, 7.0 Hz), 
3.63 (1H, dd, J = 11.4, 8.1 Hz), 3.60 (1H, dq, J = 8.6, 7.0 Hz), 3.03 (1H, 
dd, J = 11.4, 0.9 Hz), 2.42–2.34 (1H, m), 1.24 (9H, s), 1.17 (3H, t, J = 7.0 
Hz), 1.10 (3H, d, J = 6.8 Hz), 1.04 (3H, d, J = 6.9 Hz). 13C NMR (CDCl3, 
100.6 MHz) d = 202.8 (C), 199.4 (C), 177.7 (C), 169.7 (C), 91.0 (C), 79.5 
(CH), 73.3 (CH), 72.5 (CH), 71.7 (CH), 66.6 (CH2), 38.5 (C), 30.8 (CH), 
30.5 (CH2), 27.0 (CH3), 19.1 (CH3), 17.5 (CH3), 14.7 (CH3). HRMS (+ESI): 
m/z calcd for [M–OC2H5]+ C22H22Co2NO9S2: 625.9394, found: 625.9394; 
m/z calcd for [M+Na]+ C24H27Co2NNaO10S2: 693.9633, found: 693.9640. 
(S)-N-[(2R,3R)-Hexacarbonyl[µ-η4-(3-ethoxy-5-phenyl-2-pivaloyloxy-
4-pentynoyl)dicobalt(Co-Co)]-4-isopropyl-1,3-thiazolidine-2-thione 
(14k): The reaction was carried out as described in General Procedure 
using (Me3P)2NiCl2 (7.0 mg, 25 µmol, 5 mol%), 7 (152 mg, 0.5 mmol), 
hexacarbonyl μ-[η4-(1,1-diethoxy-3-phenylpropyne)]dicobalt (k, 368 mg, 
0.75 mmol), and TESOTf (249 µL, 1.10 mmol). The crude was purified by 
column chromatography (from hexanes/CH2Cl2 50:50 to 30:70) to give 277 
mg (0.37 mmol, 74% yield) of 14k as a deep maroon solid. Mp 109–111 
ºC. Rf (hexanes/CH2Cl2 30:70) = 0.50. IR (ATR) n = 2960, 2922, 2090, 
2045, 2011, 1727, 1706, 1362, 1169, 1122 cm–1. 1H NMR (CDCl3, 400 
MHz) d = 7.76–7.74 (2H, m), 7.35–7.26 (3H, m), 6.56 (1H, d, J = 1.9 Hz), 
5.88 (1H, d, J = 1.9 Hz), 5.20 (1H, ddd, J = 8.5, 5.4, 1.2 Hz), 3.80 (1H, dq, 
J = 8.7, 7.0 Hz), 3.66 (1H, dd, J = 11.5, 8.5 Hz), 3.56 (1H, dq, J = 8.7, 7.0 
Hz), 3.07 (1H, dd, J = 11.5, 1.2 Hz), 2.44–2.32 (1H, m), 1.21 (3H, t, J = 7.0 
Hz), 1.11 (3H, d, J = 6.9 Hz), 1.04 (9H, s), 1.01 (3H, d, J = 6.9 Hz), 0.89 
(9H, s). 13C NMR (CDCl3, 100.6 MHz) d = 203.1 (C), 199.3 (C), 178.9 (C), 
167.7 (C), 137.7 (C), 130.4 (CH), 128.6 (CH), 127.7 (CH), 93.6 (C), 91.1 
(C), 79.5 (CH), 75.5 (CH), 72.5 (CH), 68.2 (CH2), 38.5 (C), 30.7(CH), 30.5 
(CH2), 26.5 (CH3), 19.1 (CH3), 17.1 (CH3), 15.0 (CH3). HRMS (+ESI): m/z 
calcd for [M–OC2H5–CO]+ C22H26Co2NO3S2: 534.0013, found: 534.0000; 
m/z calcd for [M–OC2H5]+ C28H26Co2NO9S2: 701.9707, found: 701.9704. 
(S)-N-[(2R,3R)-3-Allyloxy-3-(4-methoxyphenyl)-2-
pivaloyloxypropanoyl]-4-isopropyl-1,3-thiazolidine-2-thione (14m): 
The reaction was carried out as described in General Procedure using 
(Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 2.5 mol%), 7 (152 mg, 0.5 mmol), 4-
methoxybenzaldehyde diallyl acetal (m, 129 mg, 0.55 mmol), and TESOTf 
(130 µL, 0.58 mmol). The crude was purified by column chromatography 
(from hexanes/CH2Cl2 80:20 to 40:60) to give 179 mg (0.36 mmol, 73% 
yield) of 14m as a yellow solid. Mp 89–90 ºC. Rf (hexanes/CH2Cl2 40:60) 
= 0.35. [α]D20 = +241 (c = 1.00, CHCl3). IR (ATR) n = 2962, 2929, 2873, 
1720, 1702, 1609, 1509, 1357, 1257, 1175, 1149 cm–1. 1H NMR (CDCl3, 
400 MHz) d = 7.40–7.38 (2H, m), 7.07 (1H, d, J = 7.4 Hz), 6.89–6.87 (2H, 
m), 5.82–5.72 (1H, m), 5.25 (1H, ddd, J = 8.2, 6.0, 0.9 Hz), 5.21 (1H, dq, 
J = 17.2, 1.6 Hz), 5.10 (1H, dq, J = 10.5, 1.6 Hz), 4.80 (1H, d, J = 7.4 Hz), 
3.91 (1H, ddt, J = 12.9, 4.7, 1.6 Hz), 3.81 (3H, s), 3.75 (1H, ddt, J = 12.9, 
6.1, 1.6 Hz), 3.61 (1H, dd, J = 11.4, 8.2 Hz), 3.01 (1H, dd, J = 11.4, 0.9 
Hz), 2.37–2.25 (1H, m), 1.09 (9H, s), 1.08 (3H, d, J = 6.5 Hz), 1.00 (3H, d, 
J = 6.9 Hz). 13C NMR (CDCl3, 100.6 MHz) d = 202.6 (C), 177.6 (C), 170.2 
(C), 159.7 (C), 134.1 (CH), 129.7 (C), 129.5 (CH), 117.0 (CH2), 113.5 (CH), 
80.6 (CH), 73.1 (CH), 71.7 (CH), 69.2 (CH2), 55.2 (CH3), 38.4 (C), 30.6 
(CH), 30.4 (CH2), 26.8 (CH3), 19.1 (CH3), 17.7 (CH3). HRMS (+ESI): m/z 
calcd for [M–OC3H5]+ C21H28NO4S2: 422.1454, found: 422.1442; m/z calcd 
for [M+Na]+ C24H33NNaO5S2: 502.1692, found: 502.1687. 
(S)-N-[(2R,3R)-3-Benzyloxy-3-(4-methoxyphenyl)-2-
pivaloyloxypropanoyl]-4-isopropyl-1,3-thiazolidine-2-thione (14n): 
The reaction was carried out as described in General Procedure using 
(Me3P)2NiCl2 (3.5 mg, 12.5 µmol, 2.5 mol%), 7 (152 mg, 0.5 mmol), 4-
methoxybenzaldehyde dibenzyl acetal (n, 184 mg, 0.55 mmol), and 
TESOTf (130 µL, 0.58 mmol). The crude was purified by column 
chromatography (hexanes/EtOAc 90:10) to give 183 mg (0.35 mmol, 69% 
yield) of 14n as a yellow oil. Rf (hexanes/EtOAc 90:10) = 0.40. [α]D20 = 
+137.5 (c = 1.00, CHCl3). IR (ATR) n = 2962, 2870, 1724, 1690, 1605, 
1509, 1357, 1249, 1171, 1142 cm–1. 1H NMR (CDCl3, 400 MHz) d = 7.44–
7.42 (2H, m), 7.30–7.21 (5H, m), 7.04 (1H, d, J = 7.1 Hz), 6.91–6.87 (2H, 
m), 5.19 (1H, ddd, J = 8.2, 5.9, 0.8 Hz), 4.88 (1H, d, J = 7.1 Hz), 4.46 (1H, 
d, J = 12.1 Hz), 4.25 (1H, d, J = 12.1 Hz), 3.81 (3H, s), 3.57 (1H, dd, J = 
11.4, 8.2 Hz), 2.96 (1H, dd, J = 11.4, 0.8 Hz), 2.25–2.14 (1H, m), 1.10 (9H, 
s), 0.91 (3H, d, J = 6.8 Hz), 0.88 (3H, d, J = 6.9 Hz). 13C NMR (CDCl3, 
100.6 MHz) d = 202.6 (C), 177.6 (C), 169.8 (C), 159.7 (C), 137.7 (C), 129.6 
(CH), 129.3 (C), 128.0 (CH), 127.4 (CH), 127.3 (CH), 113.5 (CH), 80.9 
(CH), 73.2 (CH), 71.6 (CH), 70.3 (CH2), 55.2 (CH3), 38.3 (C), 30.6 (CH), 
30.4 (CH2), 26.8 (CH3), 18.9 (CH3), 17.3 (CH3). HRMS (+ESI): m/z calcd 
for [M–OBn]+ C21H28NO4S2: 422.1454, found: 422.1447; m/z calcd for 
[M+Na]+ C28H35NNaO5. 
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Tiny amounts of commercially available and easy to handle (Me3P)2NiCl2 trigger the 
stereoselective aldol addition of chiral N-2-pivaloyloxyacetyl thiazolidinethione 7 to 
acetals to provide the corresponding anti glycolate adducts in a highly efficient 
manner 
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